1. Home
  2. CDW vs ASND Comparison

CDW vs ASND Comparison

Compare CDW & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CDW Corporation

CDW

CDW Corporation

N/A

Current Price

$151.80

Market Cap

16.9B

ML Signal

N/A

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

N/A

Current Price

$240.33

Market Cap

17.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDW
ASND
Founded
1984
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.9B
17.7B
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
CDW
ASND
Price
$151.80
$240.33
Analyst Decision
Buy
Strong Buy
Analyst Count
8
16
Target Price
$164.88
$281.50
AVG Volume (30 Days)
1.6M
562.0K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
1.86%
N/A
EPS Growth
1.38
N/A
EPS
3.97
N/A
Revenue
$10,768,600,000.00
N/A
Revenue This Year
$4.08
$96.35
Revenue Next Year
$4.01
$44.91
P/E Ratio
$38.73
N/A
Revenue Growth
6.32
N/A
52 Week Low
$97.12
$186.05
52 Week High
$169.18
$282.15

Technical Indicators

Market Signals
Indicator
CDW
ASND
Relative Strength Index (RSI) 58.92 36.14
Support Level $127.04 $213.28
Resistance Level $154.39 $249.89
Average True Range (ATR) 6.27 9.47
MACD 0.45 -1.25
Stochastic Oscillator 77.48 25.53

Price Performance

Historical Comparison
CDW
ASND

About CDW CDW Corporation

CDW Corp is a multi-brand provider of information technology (IT) solutions to businesses, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's offerings range from hardware and software products to integrated IT solutions and services, including on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. Its reportable segments are Corporate, Small Business, Public, and Other. The Corporate and Small Business segments serve US private sector business customers, while the Public segment consists of government agencies and education and healthcare institutions in the US. The Corporate segment generates the majority of its revenue in the United States.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: